CellCrine Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
CellCrine Inc. - overview
Location
-, -, US
Primary Industry
Biotechnology
About
Based in the US, CellCrine Inc. provides defined cell culture conditions for primary cells and cell lines. In September 2022, the firm raised a specific amount of seed funding from investor SOSV. As of 2022, the company is headed by its CEO Dr.
Rodolfo Faudoa. And the company was co-founded by Octavio Gonzalez. The company offers regenerative technology that improves cell growth. Additionally, it provides serum-free media supplements that are designed for each type of cell.
The firm’s cell line and strict cell culture conditions enable the production of bio-activated growth-promoting factors.
Current Investors
SOSV
Primary Industry
Biotechnology
Sub Industries
Meat, Poultry & Seafood Products, Biotechnology
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.